3. Summary
Global Market Direct’s pharmaceuticals report, “High Point
Pharmaceuticals, LLC - Product Pipeline Review - 2012” provides data on
the High Point Pharmaceuticals, LLC’s research and development focus. The
report includes information on current developmental pipeline, complete
with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets
Direct’s proprietary databases, High Point Pharmaceuticals, LLC’s corporate
website, SEC filings, investor presentations and featured press releases,
both from High Point Pharmaceuticals, LLC and industry-specific third party
sources, put together by Global Markets Direct’s team.
4. Scope
- High Point Pharmaceuticals, LLC - Brief High Point Pharmaceuticals, LLC overview
including business description, key information and facts, and its locations and
subsidiaries.
- Review of current pipeline of High Point Pharmaceuticals, LLC human therapeutic
division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.
Reasons to buy
- Evaluate High Point Pharmaceuticals, LLC’s strategic position with total access to
detailed information on its product pipeline.
- Assess the growth potential of High Point Pharmaceuticals, LLC in its therapy areas
of focus.
- Identify new drug targets and therapeutic classes in the High Point
Pharmaceuticals, LLC’s R&D portfolio and develop key strategic initiatives to
reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill
portfolio gaps.
5. Table of Contents :
List of Tables 3
List of Figures 3
High Point Pharmaceuticals, LLC Snapshot 4
Key Information 4
Key Facts 4
High Point Pharmaceuticals, LLC – Research and Development Overview
5
Key Therapeutic Areas 5
High Point Pharmaceuticals, LLC – Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products – Monotherapy 8
High Point Pharmaceuticals, LLC – Pipeline Products Glance 9
High Point Pharmaceuticals, LLC Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Phase I Products/Combination Treatment Modalities 10
High Point Pharmaceuticals, LLC – Drug Profiles 11
HPP-404 11
Product Description 11……………….
6. Please follow link if you want More Related
Reports :
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product
Pipeline Review – 2012&PubId=&pagenum=1
